Need professional-grade analysis? Visit stockanalysis.com
$39.10M
N/A
N/A
N/A
Scynexis Inc (SCYX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.03, down 2.83% from the previous close.
Over the past year, SCYX has traded between a low of $0.58 and a high of $1.18. The stock has lost 3.3% over this period. It is currently 12.7% below its 52-week high.
Scynexis Inc has a market capitalization of $39.10M.
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Side-by-side comparison against top Healthcare peers.